8 October 2026 | 3PM BST | Free to attend

Join this free webinar to discover how a strategic, tiered approach to human safety assessment can help you build the right evidence, reduce unnecessary testing and move towards regulatory approval with greater confid

Is your safety strategy built for regulatory approval?

For novel foods, food improvement agents and emerging technologies, getting from concept to market can mean navigating complex testing requirements, evolving regulatory expectations and difficult decisions about which evidence you actually need.

The wrong approach can cost time, money and valuable opportunities.

Join this free webinar to discover how a strategic, tiered approach to human safety assessment can help you build the right evidence, reduce unnecessary testing and move towards regulatory approval with greater confidence.

Register now through your New Food membership.

Why attend?

You’ll discover how to:

  • Build a smarter testing strategy from early screening through to regulatory-ready studies
  • Use NAMs and in vitro approaches alongside established methods to strengthen your safety evidence
  • Apply the 3Rs responsibly while building a robust weight-of-evidence dossier
  • Navigate evolving regulatory expectations from EFSA and other global authorities

Avoid costly missteps by understanding what evidence is needed, when it’s needed and how to structure your programme

From concept to compliance, make every study count

Get practical insight into how chemistry, metabolism, toxicology, NAMs and regulatory strategy can work together to create a scientifically robust safety programme.

Join live to put your questions to our experts during the Q&A.

Can’t attend live? Register to watch on demand.

Santino De’Rosa, Study Director, General Toxicology | Labcorp  

Santino De’Rosa holds a BSc (Hons) in Biological Sciences from the University of Suffolk and brings more than seven years of in vivo toxicology experience at Labcorp. He began his career with Labcorp as a Study Coordinator, supporting Study Directors in the conduct of GLP-compliant studies before advancing to the role of Study Director, a position he has held for the past five years.

His expertise spans a broad spectrum of study designs, from short-term dose range finding to long-term carcinogenicity and combined toxicity studies, across both pharmaceutical programs and OECD regulatory frameworks. Santino also brings significant experience in developmental and reproductive toxicology, as well as novel food safety study planning, making him a particularly valuable voice for audiences engaged in emerging food safety science.

Dr Darren Kidd PhD, Scientific Specialist & Subject Matter Expert, NAMs and In Vitro Alternatives  

Dr Darren Kidd is a Scientific Specialist for the in vitro Toxicology group at Labcorp (Harrogate) who focus on in vitro alternatives and New Approach Methodologies (NAMs) spanning multiple industry sectors. He holds a degree in Biological Sciences from the University of Plymouth (UK) and a PhD in in vitro gene mutation from the University of York (UK). He has worked at Labcorp (formerly Covance) for more than 25 years and is currently responsible for the scientific development and advancement of the in vitro alternatives lab.

In that time, he has been instrumental in validating many in vitro OECD Test Guidelines as client services as well as promoting the adoption of new technologies within his department. He regularly presents at national and international scientific meetings, actively participates on multiple international workgroups and has authored or co-authored several publications with relevance to NAMs. He is also a member of the Labcorp NAMs Leadership Team.

Dr. Elizabeth Lewis, Scientific & Regulatory Adviser (Chemistry), NutraSteward   

Dr. Lewis joined NutraSteward as Director in 2016. She has an established track record of providing consultancy services to clients wishing to navigate the regulatory approval processes for novel food and animal feed ingredients. Over the past 10 years, she has collaborated closely with numerous international clients to develop robust regulatory strategies to market. 

She has extensive experience of the preparation, submission and stewardship of successful scientific applications for novel food and feed ingredients in Europe, the U.S. and Canada. In this role, she has advised clients on the design and placement of studies to support the safety and efficacy of a wide range of ingredients including additives, functional food ingredients and new sources of vitamins and minerals. Additionally, she has developed a strong network of contacts within European, U.S. and Canadian regulatory bodies and academic institutions.

 

 

 

 

Is the panel discussion free?

Yes – there is no charge to watch the panel discussion, either live or on-demand.

When will the panel discussion take place?

8 October at 3PM BST

Can I watch it later?

The panel discussion will become available to watch on-demand shortly after the live webinar takes place.

What are the benefits of attending live?

You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session.

How long will the panel discussion be?

This panel discussion will last up to an hour.

What do I need to watch this panel discussion?

All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.

Register now through your New Food membership.

 

Human safety assessment for novel foods: de-risking the path from concept to compliance

2026-10-08T14:00:00
2026-10-08T14:00:002026-10-08T15:00:00
Online